Week-in-Review

Week in Review

Week in Review

A federal court rules DACA unlawful, the White House issues guidance for federal climate and energy investments, and more…

Week in Review

Week in Review

President Biden signs an executive order to strengthen antitrust enforcement, FDA commissioner requests a federal investigation of a new Alzheimer’s drug, and more…

Week in Review

Week in Review

The FDA updates guidance on a new Alzheimer’s drug, the Chinese government increases scrutiny on Chinese companies that are publicly listed overseas, and more…

Week in Review

Week in Review

President Biden signs resolutions to overturn Trump-era rules, the Supreme Court upholds voting restrictions, and more…

Week in Review

Week in Review

President Biden releases gun violence prevention strategy, the Supreme Court strikes down the FHFA’s structure, and more…

Week in Review

Week in Review

The Supreme Court rejects a challenge to the Affordable Care Act, the Biden Administration releases its regulatory agenda, and more…

Week in Review

Week in Review

FDA approves a new drug to treat Alzheimer’s disease, OSHA issues a rule to protect health care employees from COVID-19, and more…

Week in Review

Week in Review

The Supreme Court rules tribal police can stop non-Indian persons in certain contexts, DHS ends a program against asylum seekers, and more…

Week in Review

Week in Review

The Supreme Court rules that Guam can seek cleanup costs from the Navy, the FAA issues a final rule that will create a database of pilot records, and more…

Week in Review

Week in Review

The Senate disapproves a Trump-era rule on employer discrimination complaints, President Biden signs law to combat hate crimes, and more…

Week in Review

Week in Review

FDA authorizes Pfizer vaccine for ages 12-15, President Biden announces cybersecurity enhancements, and more…

Week in Review

Week in Review

FDA considers expanding vaccine use to children, President Biden increases refugee admissions, and more…